Cite

HARVARD Citation

    Mease, P. et al. (2021). Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Annals of the rheumatic diseases. 80 (3), pp. 312-320. [Online]. 
  
Back to record